Evidence map›Paper›PMID 17567769›Full record

ArticleClinical and vaccine immunology : CVI2007

Dominant epitopes of the C6 diagnostic peptide of Borrelia burgdorferi are largely inaccessible to antibody on the parent VlsE molecule.

Monica E Embers, Mary B Jacobs, Barbara J B Johnson, Mario T Philipp

Open access · diamondAbstract read
In one paragraph

Article in Clinical and vaccine immunology : CVI, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 36 citations in OpenAlex.

  1. Serological correlates of disseminatedMicrobiology spectrum · 2026
    Article
  2. Article
  3. Diagnostic probability classification in suspected borreliosis by a novelFrontiers in cellular and infection microbiology · 2023
    Article
  4. Detection ofVeterinary sciences · 2022
    Article
  5. Evolution of theMicrobiology spectrum · 2022
    Article
  6. Article
  7. Laboratory Diagnosis of Lyme Borreliosis.Clinical microbiology reviews · 2021
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Utility ofBioMed research international · 2018
    Article
  14. Article
  15. Article
  16. Evaluation of Modified 2-Tiered Serodiagnostic Testing Algorithms for Early Lyme Disease.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Article
  17. Article
  18. Article
  19. Antigenic Variation in Bacterial Pathogens.Microbiology spectrum · 2016
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Monica E EmbersDivision of Bacteriology and Parasitology, Tulane National Primate Research Center, Tulane University Health Sciences Center, 18703 Three Rivers Road, Covington, LA 70433, USA. Philipp@tulane.edu
Mary B Jacobs
Barbara J B Johnson
Mario T Philipp
Tulane University · USCenters for Disease Control and Prevention · USNational Center for Infectious Diseases · US

Funding

ZCM:A NOVEL BROAD-SPECTRUM MICROBICIDE FOR SEXUALLY TRANSMITTED INFECTIONSP51RR000164 · NCRR · TULANE UNIVERSITY OF LOUISIANA · PI MARX, PRESTON A · 1985 to 2011
$100.1M
'Lyme disease: A possible test for cureR01AI049976 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI PHILIPP, MARIO TOMAS · 2001 to 2003
$484k
NCRR NIH HHS P51 RR000164NCRR NIH HHS RR00164NIAID NIH HHS R01 AI049976NIAID NIH HHS R01-AI49976
6 · The paper itself

Abstract

Lyme borreliosis (LB) is a disease for which antibody-based detection assays are often required for diagnosis. The variable surface molecule VlsE and IR6, one of its invariable regions, are commonly targeted by the antibody response in infected individuals. A series of enzyme-linked immunosorbent assays was performed to comparatively examine the antibody responses of North American LB patients (n = 37) to VlsE and invariable segments of this molecule. Both immunoglobulin M (IgM) and IgG responses to full-length VlsE and to peptides reproducing invariable regions 2, 4, and 6, as well as the invariable domains at the amino and carboxyl termini of VlsE, were assessed. The proportions and specificities of reactivity to the invariable segments were tested by using cognate peptides as competitors for VlsE binding by patient serum antibodies. IR6 epitopes (by the C6 peptide) were found to dominate the response to invariable segments. IR6 (C6)-specific antibodies were detected in 78% of the serum specimens, whereas <40% of patients generated antibodies that bound the N- or C-terminal domain and <12% of patients responded to either IR2 or IR4. Interestingly, 15 of 37 patients generated IgG antibodies that reacted with C6 but not with VlsE. Conversely, IgM responses were frequent for VlsE but not for invariable segments. A representative number of the serum specimens (n = 8) that contained IgG antibodies reacting with both C6 and VlsE was assessed in competition experiments, using C6 as a competitor. Only half of these specimens contained IgG antibodies whose binding to VlsE could be inhibited >50% by competition with the added C6 peptide. The median percent inhibition was 45.5%. These findings indicate that IR6 epitopes are largely concealed from the VlsE molecular surface and that full-length VlsE-based diagnosis likely detects antibodies to conformational and/or variable region epitopes.

Indexed as

Antibodies, BacterialAntibody SpecificityAntigens, BacterialBacterial ProteinsBinding, CompetitiveBorrelia burgdorferi GroupEnzyme-Linked Immunosorbent AssayHumansImmunodominant EpitopesImmunoglobulin GImmunoglobulin MLipoproteinsLyme DiseasePeptide FragmentsAntibodies, BacterialAntigens, BacterialBacterial ProteinsImmunodominant EpitopesImmunoglobulin GImmunoglobulin MLipoproteinsPeptide FragmentsVlsE protein, Borrelia burgdorferi

Identifiers

PMID17567769
PMCPMC2044495
OpenAlexW2128616785

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.